Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panc-ICG lymphatic flow imaging study in pancreatic tumor surgery
jRCTs031230716Active, not recruiting
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in Pancreatic neoplasia. Primary endpoint: Identification rate of lymphatic flow. Started Mar 2024; status: active, not recruiting.
02
Drugs
indocyanine green
03
Conditions
Pancreatic neoplasia
Beyond the preview
Go deeper on jRCTs031230716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230716.